HARP
$23.01
Revenue | $4.45Mn |
Net Profits | $-1.8Mn |
Net Profit Margins | -40.51% |
Harpoon Therapeutics Inc’s revenue fell -67.33% since last year same period to $4.45Mn in the Q3 2023. On a quarterly growth basis, Harpoon Therapeutics Inc has generated -78% fall in its revenue since last 3-months.
Harpoon Therapeutics Inc’s net profit jumped 84.18% since last year same period to $-1.8Mn in the Q3 2023. On a quarterly growth basis, Harpoon Therapeutics Inc has generated -269.84% fall in its net profits since last 3-months.
Harpoon Therapeutics Inc’s net profit margin jumped 51.57% since last year same period to -40.51% in the Q3 2023. On a quarterly growth basis, Harpoon Therapeutics Inc has generated -872.11% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.64 |
EPS Estimate Current Year | -0.64 |
Harpoon Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a 80% jump from last quarter’s estimates.
Harpoon Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.64.
Earning Per Share (EPS) | -0.46 |
Harpoon Therapeutics Inc’s earning per share (EPS) fell -31.43% since last year same period to -0.46 in the Q3 2023. This indicates that the Harpoon Therapeutics Inc has generated -31.43% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-05-11 | -0.38 | -0.31 | 18.42% |
2023-11-09 | -3.2 | -0.46 | 85.63% |
2023-08-09 | -0.34 | 0.03 | 108.82% |